Lithium Controlled-Release and Extended-Release Tablets and Pexidartinib Hydrochloride
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Pexidartinib Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: pexidartinib
Brand name: Turalio
Synonyms: Pexidartinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Pfizerpen
- Lithium Controlled-Release and Extended-Release Tablets-Pharaon Tea
- Lithium Controlled-Release and Extended-Release Tablets-Pharmorubicin Pfs
- Lithium Controlled-Release and Extended-Release Tablets-Phazyme
- Lithium Controlled-Release and Extended-Release Tablets-Phazyme Liquid Gas Relief, Maximum Strength
- Lithium Controlled-Release and Extended-Release Tablets-Phena-Plus
- Pexidartinib Hydrochloride-Lithium ER
- Pexidartinib Hydrochloride-Lithium Oral Solution
- Pexidartinib Hydrochloride-Lithium Salts
- Pexidartinib Hydrochloride-Lithium Syrup and Oral Solution
- Pexidartinib Hydrochloride-Lithobid
- Pexidartinib Hydrochloride-Lithostat